Your search returned 2 results.

Results
	1.	Capecitabine in Combination with Docetaxel in First Line in HER2-Negative Metastatic Breast Cancer: an Observational Study. [electronic resource] by Kószó, Renáta Sántha, Dóra Büdi, László Erfán, József Győrfy, Károly Horváth, Zsolt Kocsis, Judit Landherr, László Hitre, Erika Máhr, Károly Pajkos, Gábor Pápai, Zsuzsanna Kahán, Zsuzsanna Producer: 20180320 In: Pathology oncology research : POR vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor-Positive Metastatic Breast Cancer: The MANTA Phase 2 Randomized Clinical Trial. [electronic resource] by Schmid, Peter Zaiss, Matthias Harper-Wynne, Catherine Ferreira, Marta Dubey, Sidharth Chan, Stephen Makris, Andreas Nemsadze, Gia Brunt, Adrian M Kuemmel, Sherko Ruiz, Isabel Perelló, Antonia Kendall, Anne Brown, Janet Kristeleit, Hartmut Conibear, John Saura, Cristina Grenier, Julien Máhr, Károly Schenker, Michael Sohn, Joohyuk Lee, Keun Seok Shepherd, Christopher J Oelmann, Elisabeth Sarker, Shah-Jalal Prendergast, Aaron Marosics, Patricia Moosa, Atiyyah Lawrence, Cheryl Coetzee, Carike Mousa, Kelly Cortés, Javier Publication details: JAMA oncology Nov 2019 In: JAMA oncology vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)